Definition
Antidepressants are a class of medications that are used primarily in the treatment of clinically severe mood or anxiety disorders. The majority of effective antidepressants currently in use enhance neurotransmission of serotonin and/or norepinephrine. Generally, this is achieved by blocking the reuptake of the neurotransmitter substance(s), inhibiting the enzymes responsible for its metabolism, or directly stimulating the postsynaptic receptors (Iversen, Iversen, Bloom, & Roth, 2009). Several antidepressants are also used in treating generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder (Bourin & Lambert, 2002). Other conditions for which antidepressants have demonstrated efficacy include eating disorders (Powers & Bruty, 2009), neuropathic pain (O’Connor & Dworkin, 2009), stress incontinence, nocturnal eneuresis, ejaculatory disorders (Michel, Ruhe, de Groot, Castro, & Oelke, 2006), migraine headaches, fibromyalgia (Stone, Viera, & Parman, 2003),...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Readings
Bourin, M., & Lambert, O. (2002). Pharmacotherapy of anxious disorders. Human Psychopharmacology: Clinical Experimental, 17, 383–400.
Chung, B., Suzuki, A. R., & McGough, J. J. (2002). New drugs for treatment of attention-deficit/hyperactivity disorder. Expert Opinion Emerging Drugs, 7, 269–276.
FDA Press Release. Extracted from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108905.htm on 1/21/2010
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., et al. (2010). Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA, 303, 47–53.
Grant, J. E., & Grosz, R. (2004). Pharmacotherapy outcome in older pathological gamblers: A preliminary investigation. Journal of Geriatric Psychiatry and Neurology, 17, 9–12.
Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332–339.
Horstmann, S., & Binder, E. B. (2009). Pharmacogenomics of antidepressant drugs. Pharmacology and Therapeutics, 124, 57–73.
Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Antidepressants and Anxiolytics. Introduction to Neuropsychopharmacology (pp. 306–335). New York: Oxford University Press.
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and Drug Administration. PlOS Medicine, 5, e45.
Michel, M. C., Ruhe, H. G., de Groot, A. A., Castro, R., & Oelke, M. (2006). Tolerability of amine uptake inhibitors in urologic diseases. Current Drug Safety, 1, 73–85.
O’Connor, A. B., & Dworkin, R. H. (2009). Treatment of neuropathic pain: An overview of recent guidelines. American Journal of Medicine, 122(Suppl. 10), S22–32.
Powers, P. S., & Bruty, H. (2009). Pharmacotherapy for eating disorders and obesity. Child Adolescent Psychiatric Clinics of North America, 18, 175–187.
Rihmer, Z., & Akiskal, H. (2006). Do antidepressants t(h)reat(en) depressives? Toward a clinical judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. Journal of Affective Disorders, 94, 3–13.
Skolnick, P., Popik, P., & Trullas, R. (2009). Glutamate-based antidepressants: 20 years on. Trends in Pharmacological Sciences, 30, 563–569.
Stone, K. J., Viera, A. J., & Parman, C. L. (2003). Off-label applications for SSRIs. American Family Physician, 68, 498–504.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this entry
Cite this entry
Tschanz, J.T., Treiber, K. (2011). Antidepressants. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79948-3_1771
Download citation
DOI: https://doi.org/10.1007/978-0-387-79948-3_1771
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79947-6
Online ISBN: 978-0-387-79948-3
eBook Packages: Behavioral Science